Our finding of significantly higher PDGFB expression among COVID-19 patients ages 40 years and older in the middle stage (11–21 days after the symptom onset) compared to the early stage (0–10 days) is consistent with the observation that COVID-19 symptoms peak 10 days after symptom onset [30]. Here, PDGFB is linked to COVID-19.